This Act guarantees individuals the right to obtain and receive information about FDA-approved medicines and protects healthcare providers who offer them from restrictive government rules.
Deborah Ross
Representative
NC-2
The Right to FDA-Approved Medicines Act guarantees individuals the right to obtain and receive information about medicines already approved by the FDA. This law preempts and overrides conflicting federal and state regulations that restrict access to or the provision of these approved drugs by healthcare providers. It establishes strong enforcement mechanisms, allowing both the Attorney General and private citizens to sue states that violate these protections.
The “Right to FDA-Approved Medicines Act” is straightforward: if the FDA has approved a drug, you have a guaranteed right to get it, and your doctor has the right to prescribe it. This bill aims to cut through any existing red tape—whether state or federal—that might be preventing patients from accessing approved treatments or making it difficult for healthcare providers to offer them.
This Act essentially sets up a federal shield around FDA-approved medicines. It states clearly that no rule, written or implied, can be put in place to single out and restrict the provision of these drugs, the providers who offer them, or the facilities where they are dispensed (Sec. 4). If a state or local government wants to impose a restriction, they face a massive legal hurdle: they must prove, using “clear and convincing evidence,” that the rule actually improves access to the medicine and that there is no less restrictive way to achieve that benefit (Sec. 4).
Think of it this way: if you live in a state that has specific, unusual rules about who can prescribe a certain FDA-approved drug or where it can be sold, this bill immediately overrides those rules. The goal is uniformity. For patients, this means that if a drug is approved in Washington D.C., it should be equally available without arbitrary local restrictions in rural Texas or suburban New York. This is a big win for ensuring that medical decisions stay between you and your provider, not between your provider and a state regulator.
This law is serious about making sure it’s the final word. Section 5 states that this Act immediately “replaces and applies over any existing Federal or State laws” that conflict with it, whether those laws were written down or based on common law. It explicitly blocks states and the federal government from enforcing any rule that “blocks or limits the sale, provision, or use” of FDA-approved medicines. This is called preemption, and here, it’s exceptionally broad.
For state and local governments, this is a significant change. It means they lose a lot of their power to regulate the provision of approved drugs. If a county tried to pass an ordinance restricting the use of a specific FDA-approved medication, that ordinance is now null and void the moment this Act takes effect. However, the bill is careful to carve out one major exception: it does not override federal laws dealing with health insurance coverage, including Medicare and Medicaid (Sec. 5). So, while the state can’t stop you from getting the drug, your insurer can still use existing federal rules to decide whether they pay for it.
Perhaps the most powerful part of the Act is the enforcement mechanism laid out in Section 7. If a state or a state official tries to enforce a rule that violates this new right to medicine, both the U.S. Attorney General and private citizens who are harmed can sue them directly. This is a massive deal because the Act explicitly removes the state’s usual shield against being sued—the immunity based on the Tenth or Eleventh Amendments (Sec. 7).
This means that if you’re a patient or a doctor facing a restrictive state rule, you don’t have to wait for the federal government to step in. You can go straight to federal court. Furthermore, if you win, the state has to pay your legal costs, including attorney’s fees. This private right of action is a powerful tool designed to ensure that state agencies think twice before implementing policies that might run afoul of this new federal guarantee.